|
|
News Breaks | | | | March 21, 2013 | | 07:15 EDT |  | THLD, SI | Threshold Pharmaceuticals acquires [18F]HX4 from Siemens Healthcare
Threshold Pharmaceuticals (THLD) announced a global agreement with Siemens Healthcare (SI) to acquire its investigational agent [18F]HX4, a radiolabeled hypoxia Positron Emission Tomography, or PET, tracer. [18F]HX4 could potentially be used as a companion diagnostic to hypoxia-targeted therapeutics based on Threshold's drug discovery platform. Threshold initially intends to develop [18F]HX4 to determine a patient's tumor hypoxia profile, which may identify patients who will best respond to Threshold's hypoxia-targeted therapeutics. Under the terms of the agreement, Siemens will transfer ownership and existing preclinical, clinical and manufacturing data related to [18F]HX4 to Threshold. | |
|
News For THLD;SI From The Last 14 Days Check below for free stories on THLD;SI the last two weeks. |
|
|
| May 7, 2013 | | 11:04 EDT |  | SI | Dresser-Rand turning into takeover candidate, Bloomberg reports
 Subscribe for More Information | | | 07:24 EDT |  | THLD | Mizuho Securities to host a conference
Subscribe for More Information | | | May 6, 2013 | | 10:01 EDT | | SI | Siemens signs 15-year wind service extensions in North America
Subscribe for More Information | |
|
|
|
|
|
|
